GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vilacto Bio Inc (GREY:VIBI) » Definitions » Equity-to-Asset

Vilacto Bio (Vilacto Bio) Equity-to-Asset : -6.25 (As of Jun. 2019)


View and export this data going back to 2013. Start your Free Trial

What is Vilacto Bio Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Vilacto Bio's Total Stockholders Equity for the quarter that ended in Jun. 2019 was $-2.51 Mil. Vilacto Bio's Total Assets for the quarter that ended in Jun. 2019 was $0.40 Mil. Therefore, Vilacto Bio's Equity to Asset Ratio for the quarter that ended in Jun. 2019 was -6.25.

The historical rank and industry rank for Vilacto Bio's Equity-to-Asset or its related term are showing as below:

VIBI's Equity-to-Asset is not ranked *
in the Biotechnology industry.
Industry Median: 0.67
* Ranked among companies with meaningful Equity-to-Asset only.

Vilacto Bio Equity-to-Asset Historical Data

The historical data trend for Vilacto Bio's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vilacto Bio Equity-to-Asset Chart

Vilacto Bio Annual Data
Trend Mar13 Mar14 Mar15 Mar16 Mar17 Mar18 Mar19
Equity-to-Asset
Get a 7-Day Free Trial - - -1.96 -3.02 -6.36

Vilacto Bio Quarterly Data
Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4.46 -11.30 -10.20 -6.36 -6.25

Competitive Comparison of Vilacto Bio's Equity-to-Asset

For the Biotechnology subindustry, Vilacto Bio's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vilacto Bio's Equity-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Vilacto Bio's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Vilacto Bio's Equity-to-Asset falls into.



Vilacto Bio Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Vilacto Bio's Equity to Asset Ratio for the fiscal year that ended in Mar. 2019 is calculated as

Equity to Asset (A: Mar. 2019 )=Total Stockholders Equity/Total Assets
=-3.423/0.538
=-6.36

Vilacto Bio's Equity to Asset Ratio for the quarter that ended in Jun. 2019 is calculated as

Equity to Asset (Q: Jun. 2019 )=Total Stockholders Equity/Total Assets
=-2.511/0.402
=-6.25

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Vilacto Bio  (GREY:VIBI) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Vilacto Bio Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Vilacto Bio's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Vilacto Bio (Vilacto Bio) Business Description

Traded in Other Exchanges
N/A
Address
Fabriksvej 48, Suite 2607, The Seagram Building, Naestved, DNK, 4700
Vilacto Bio Inc is a biotech company. It operates a fully patented Lactoactive molecule for treating conditions such as inflammatory diseases, diabetics, psoriasis, and skin issues in different levels. The company is also intended to develop Lactoactive molecule for increasing the quality of its retail and medical skin cream product as well as developing products for medical applications. Its product portfolio includes lotions, skin care creams and gels, lip balms, foot creams and oils, and others.